PMA device
SENSAR Soft Acrylic Posterior Chamber IOL
Johnson & Johnson Surgical Vision, Inc. · Intraocular Lens (HQL, Class III) · First FDA decision Feb 3, 2000, newest Sep 10, 2025Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
PMA pathway
Device trials
0
Naming "SENSAR Soft Acrylic"
MAUDE reports
0
Brand "SENSAR Soft Acrylic", since 2015
PubMed studies
0
Mentioning "SENSAR Soft Acrylic"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SENSAR Soft Acrylic Posterior Chamber IOL
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 7 decisions filed under this name.
- SENSAR Soft Acrylic Posterior Chamber IOL, SENSAR 1-piece IOL, TECNIS 1-Piece IOL, TECNIS Multifocal 1-Piece IOL, TECNISPMA supplement
P980040-S171 · Decided Sep 10, 2025 · 261 days after receipt · Normal 180 Day Track No User Fee
Device type: intraocular lens (HQL) · Ophthalmology
P980040-S098 · Decided Oct 1, 2019 · 284 days after receipt · Normal 180 Day Track
Device type: intraocular lens (HQL) · Ophthalmology
P980040-S080 · Decided Jun 2, 2017 · 53 days after receipt · Normal 180 Day Track No User Fee
Device type: intraocular lens (HQL) · Ophthalmology
3 more FDA decisions with a free account
Older decisions: P980040
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Intraocular Lenses (IOLs)National determinationOn the books80.12Updated Aug 17, 2023
- Intraocular PhotographyNational determinationOn the books80.6Updated Apr 17, 2020
- Ophthalmic Biometry for Intraocular Lens Power CalculationLocal determinationIn effectL33621Wellpoint FederalUpdated Jul 14, 2026
- Ophthalmic Biometry for Intraocular Lens Power CalculationLocal determinationIn effectL34181CGS Administrators, LLCUpdated May 29, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40385WPS Insurance CorporationUpdated May 14, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40356CGS Administrators, LLCUpdated May 14, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40367Palmetto GBAUpdated May 14, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40363National Government Services, Inc.Updated May 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "SENSAR Soft Acrylic", any status and sponsor, newest update first.
No registered device study names "SENSAR Soft Acrylic".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SENSAR Soft Acrylic", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code HQL
40,785 reports: 26,247 malfunction, 14,467 injury, 2 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
AMO Puerto Rico Manufacturing, Inc.
Z-1634-2026 · Started Feb 19, 2026 · Posted by FDA Mar 24, 2026
Reason given: Due to identifying a limited quantity of intraocular lenses that may have a haptic that sticks to the optic which prevents the lens from unfolding as consistently as expected.
Cause as FDA categorized it: Process control · Device type: Intraocular Lens (HQL)
Abbott Medical Optics Inc. (AMO)
Z-2855-2016 · Started Aug 26, 2016 · Posted by FDA Sep 21, 2016
Reason given: Abbott Medical Optics is recalling Intraocular Lenses (IOLs) because they were not being checked prior to release and this may result in the release of mislabeled IOLs.
Cause as FDA categorized it: Process control · Device type: Intraocular Lens (HQL)
Abbott Medical Optics Inc. (AMO)
Z-2856-2016 · Started Aug 26, 2016 · Posted by FDA Sep 21, 2016
Reason given: Abbott Medical Optics is recalling Intraocular Lenses (IOLs) because they were not being checked prior to release and this may result in the release of mislabeled IOLs.
Cause as FDA categorized it: Process control · Device type: Intraocular Lens (HQL)
10 more recall records with a free account
Published research
The most relevant PubMed records for "SENSAR Soft Acrylic"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code HQL.
- Clareon Aspheric Hydrophobic Acrylic Intraocular Lens with the AutonoMe Pre- Loaded Delivery SystemAlcon Laboratories, LLC · PMA 2026
- TECNIS Toric 1-Piece Intraocular Lense (IOLs)Johnson & Johnson Surgical Vision, Inc. · PMA 2020
- TECNIS Symfony Toric Extended Range of Vision IOLsJohnson & Johnson Surgical Vision, Inc. · PMA 2021
- Akreos Posterior Chamber Intraocular LensBausch & Lomb, Inc. · PMA 2021
- Acrysof Iq Toric IOL with the Ultrasert Pre Loaded Delivery System ModelsAlcon Laboratories, Inc. · PMA 2017
- Softec Hd Posterior Chamber Intraocular Lens (Pciol)Lenstec, Inc. · PMA 2014
- Posterior Chamber Intraocular LensesAaren Scientific · PMA 2001
- TECNIS Foldable Acrylic IOL with OptiEdgeJohnson & Johnson Surgical Vision, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.